P. Devarajan

Nephrology · 2003–2011

A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Nephrology — 46 citations into it; #45 of 92 by trust here, #41 by citations
• Molecular Biology — 14 citations into it
• Surgery — 14 citations into it
• Immunology — 7 citations into it
• Public Health, Environmental and Occupational Health — 5 citations into it

Whom P. Devarajan trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Joseph V. Bonventre
2. F. Tögel
3. Jeremy S. Duffield

Who trusts P. Devarajan overall

1. L. Chawla

Papers from P. Devarajan's perspective

Ordered by how strongly the researchers P. Devarajan trusts endorse each paper. Same corpus, a different order for every researcher.

1. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. (Journal of the American Society of Nephrology)
2. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. (Journal of the American Society of Nephrology)
3. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. (Journal of Clinical Investigation)
4. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. (Kidney International)
5. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. (Journal of Clinical Investigation)
6. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients* (Critical Care Medicine)
7. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. (AJP - Renal Physiology)
8. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. (New England Journal of Medicine)
9. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. (Molecules and Cells)
10. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

Their papers

• The Outcome of Neutrophil Gelatinase-Associated Lipocalin (NGAL)-positive Subclinical Acute Kidney Injury: A Multicenter Pooled Analysis of Prospective Studies (2011) — 679 citations
• Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. (2009) — 1,326 citations
• Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. (2008) — 802 citations
• Dual action of neutrophil gelatinase-associated lipocalin. (2007) — 758 citations
• Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. (2006) — 605 citations
• Update on mechanisms of ischemic acute kidney injury. (2006) — 1,005 citations
• Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. (2005) — 944 citations
• Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. (2003) — 1,757 citations